PKU Now Colorimetric Assay for L-Phenylalanine Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for monitoring L-phenylalanine levels in biological samples are cumbersome, require large sample volumes, and often suffer from interference from L-tyrosine, making them less effective for point-of-care diagnostics and monitoring of phenylketonuria (PKU).

Innovation Solution

A colorimetric assay, referred to as 'PKU Now', utilizing a test strip with multiple membrane layers and a combination of diaphorase and phenylalanine dehydrogenase, which minimizes L-tyrosine interference and allows for precise detection of L-phenylalanine levels in small biological samples, enabling point-of-care testing with high sensitivity and accuracy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional wet chemistry assays are used for L-phenylalanine determination, then measurement capability is achieved, but the procedures are cumbersome and require large sample volumes

Engineering Contradiction:
Improvesample volumeVSAvoidprocedure complexity
Core Design Contradiction:
Quantity of substanceVSEase of operation

Solution Approach 1:

The assay is segmented into distinct functional layers on a test strip: a sample application layer, a reaction layer containing phenylalanine dehydrogenase and diaphorase enzymes, and a detection layer. This segmentation allows the complex biochemical reactions to be spatially organized, enabling rapid processing of small blood spots (requiring only 25 μL or less) while simplifying the user procedure to a single drop application.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The conventional mechanical mixing and multi-step processing are replaced by capillary action and lateral flow mechanisms. The blood sample automatically wicks through the test strip layers, and reactions proceed without manual intervention, eliminating the need for complex mechanical handling while reducing sample volume requirements.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If conventional assays are used, then L-phenylalanine measurement is possible, but interference from L-tyrosine reduces measurement precision

Engineering Contradiction:
ImproveL-phenylalanine detection accuracyVSAvoidL-tyrosine interference
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

Diaphorase is introduced as an intermediary enzyme that specifically couples phenylalanine oxidation to a measurable colorimetric reaction. This intermediary step provides selectivity because diaphorase has high specificity for the phenylalanine dehydrogenase reaction product, effectively filtering out L-tyrosine interference and enabling precise measurement of L-phenylalanine even in its presence.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The assay utilizes pH optimization to enhance the specificity of phenylalanine dehydrogenase for L-phenylalanine over L-tyrosine. By controlling the pH conditions in the reaction layer, the enzyme's substrate specificity is maximized, reducing cross-reactivity with L-tyrosine and improving measurement precision.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If rapid testing is implemented for point-of-care use, then diagnostic speed is improved, but measurement precision and reliability may be compromised

Engineering Contradiction:
Improvetesting speedVSAvoidmeasurement reliability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The test strip is pre-loaded with optimized concentrations of phenylalanine dehydrogenase, diaphorase, substrates, and buffers in each layer. This preliminary preparation ensures that when the blood sample is applied, all reaction components are immediately available in the correct proportions, enabling rapid color development within minutes while maintaining reliable and reproducible results through controlled reaction conditions.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The assay employs a colorimetric detection system where the final reaction product produces a measurable color change. This color change provides a direct, visual, and quantitative readout that can be rapidly assessed at the point of care while maintaining measurement reliability through the use of chromogenic substrates with strong, distinguishable color signals that minimize variability.

Inventive Principle:
Principle #32Color changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The 'PKU Now' assay provides rapid, quantitative, and reliable measurement of L-phenylalanine levels in biological samples, reducing interference and requiring minimal sample volume, thus enhancing diagnostic and monitoring capabilities for PKU, particularly in neonates and individuals on restricted diets.

Implementation Method 1

A combination of components is comprised to elicit a measurable colored end-product from the application of a biological sample containing the substrate Phe

Methodology Applied
Scientific EffectColorimetric reaction: Chemical Bonding

Implementation Method 2

utilizing a test strip with multiple membrane layers and a combination of diaphorase and phenylalanine dehydrogenase, which minimizes L-tyrosine interference

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

utilizing a test strip with multiple membrane layers

Methodology Applied
Scientific EffectChromatographic separation: Chromatography

Data Source

PatentUS10830765B1Point-of-care device for the colorimetric determination of L-phenylalanine in biological samples
Publication Date: 2020.11.10 ANALYTICAL DIAGNOSTIC SOLUTIONS INC
  • US10830765B1 patent drawing
  • US10830765B1 patent drawing
  • US10830765B1 patent drawing

AI summary

Methods and devices for testing and monitoring L-phenylalanine in biological samples are provided.